Enzymatically hardened calcium phosphate biocement with phytic acid addition

Traditional calcium phosphate cements rely on acidic solutions to initiate hardening. However, these methods often result in limited control over setting time and final composition. Recent studies have explored alternative hardening agents to improve biocompatibility and mechanical properties. Enzymatic systems offer a promising approach by allowing precise control over the hardening process. Prior research has shown that enzymatic hardening can influence microstructure and biocompatibility. Yet, the role of phytic acid in this context remains underexplored. This gap motivated the investigation of phytic acid/phytase mixtures as a novel hardening liquid. No prior work had resolved how phytic acid affects compressive strength and cytotoxicity in calcium phosphate cements. This study aimed to address these uncertainties.

The study aimed to evaluate the properties of a new calcium phosphate cement hardened using a phytic acid/phytase mixture. The objective was to compare this cement with traditional ones hardened using sodium dihydrogen phosphate or acetic acid. The researchers focused on understanding how phytic acid affects microstructure and mechanical performance. They also assessed biocompatibility and cytotoxicity of the new cement. The motivation stemmed from the need for better control over setting time and final composition. The team sought to determine if phytic acid could improve cell behavior and enzyme activity. They also wanted to confirm if the new cement could maintain compressive strength. This work aimed to provide insights into the role of phytic acid in cement hardening.

The researchers prepared tetracalcium phosphate/monetite cements using a phytic acid/phytase mixture as the hardening liquid. The mixture was dissolved in acetic acid to form the CX cement. They compared this with cements hardened using 2% NaH2PO4 (C cement) and acetic acid only (CAC cement). The team analyzed the microstructure of CX cement using scanning electron microscopy. They measured wet and dry compressive strengths using standardized methods. Biocompatibility was assessed by testing the effect of cement extracts on cell behavior. ALP activity was measured to evaluate the impact on cell function. The team also varied the phytic acid content and reaction time to study their effects on cement properties. These methods allowed them to evaluate the role of phytic acid in cement hardening.

The CX cement showed a unique microstructure with columnar hydroxyapatite particles forming walls around agglomerates. These structures were separated by low-density zones, indicating a distinct hardening mechanism. Wet compressive strengths were similar across all cement types. However, dry compressive strengths of CX and CAC cements were about 30% higher than C cement. The CX cement extracts were noncytotoxic and supported cell growth. The cement also enhanced ALP activity, suggesting a positive effect on cell function. The final Ca/P molar ratio was effectively controlled by adjusting phytic acid content. Setting time was influenced by the phytic acid/phytase mass ratio and reaction time. These findings suggest that phytic acid can improve cement properties without compromising strength.

The study demonstrated that phytic acid/phytase mixtures can serve as effective hardening agents for calcium phosphate cements. The CX cement showed a unique microstructure with enhanced dry compressive strength. The cement was noncytotoxic and supported cell behavior, as reported by the authors. The final Ca/P ratio and setting time were controllable through phytic acid content and reaction parameters. These findings suggest that phytic acid can improve cement properties without compromising strength. The authors propose that this approach offers better control over cement composition and biocompatibility. They suggest that the CX cement could be a viable alternative to traditional cements. The study supports further exploration of enzymatic hardening in biomaterials.